EMMAC Life Sciences Limited

EMMAC Life Sciences Limited

On July 22, 2020 Andina III and EMMAC Life Sciences Limited jointly announced the signing of a non-binding letter of intent relating to a business combination. Through this transaction EMMAC would become a publicly traded company on the NASDAQ Stock Market.

EMMAC is Europe’s largest independent cannabis company, bringing together cutting-edge scientific research with the latest innovations in medical cannabis cultivation, extraction and production. With a unique supply and distribution network throughout Europe, EMMAC’s vision is to bring the life-enhancing potential of cannabis to the people who need it.